Itching is the predominant symptom of skin disease but it is ill-under
stood and a challenge for future research. Even the major nerve pathwa
ys for itch, and its relationship to pain are debatable. In inflamed s
kin, histamine plays a major role and its mode of release from mast ce
lls in, for example, chronic urticaria is now better appreciated. Tach
ykinins including substance P and cytokines including interleukin-2 ar
e evidently important peripherally. Opioid mu-receptor-dependent proce
sses activate inhibitory circuits in the central nervous system and re
gulate the extent of intensity and quality of perceived itch. It is pr
oposed that stimulation of large areas of skin such as by scratching,
generates inhibitory activity which suppresses itch excitation. Therap
eutic intervention based upon understanding these regulatory processes
is a real prospect.